Henry M Jackson Foundation for the Advancement of Military Medicine

We Advance Military Medicine!

aka HJF   |   BETHESDA, MD   |  www.hjf.org

Mission

HJF partners to advance military medicine for our nation’s warfighters.

Ruling year info

1983

President & CEO

Dr. Joseph Caravalho Jr.

Main address

6720A ROCKLEDGE DR STE 100

BETHESDA, MD 20817 USA

Show more contact info

EIN

52-1317896

NTEE code info

Management & Technical Assistance (H02)

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Sign in or create an account to view Form(s) 990 for 2019, 2018 and 2017.
Register now

Communication

Programs and results

What we aim to solve

SOURCE: Self-reported by organization

HJF serves as a vital link between the military medical community and federal and private partners. By providing research and administrative support and capabilities, HJF makes it possible for military medical researchers and clinicians to focus on research and accomplish their goals.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Clinical Breast Care Project

In 2000, the Clinical Breast Care Project was launched with the mission to lead innovative research that would eventually eradicate the disease. Twelve years later, the program became part of the John P. Murtha Cancer Center, which achieved designation by the assistant secretary of defense for health affairs as a Department of Defense Center of Excellence.

Today, the Breast Cancer Translational Research Center houses the world’s largest biorepository of high-quality human breast specimens. Located at Walter Reed National Military Medical Center, the program is a public-private partnership among HJF, Windber Research Institute in Pennsylvania and Walter Reed National Military Medical Center in Bethesda, Maryland.

The center studies biomarkers in archival breast cancer tissue and collaborates with such organizations as the National Cancer Institute’s Genome Atlas Project.

Population(s) Served
Adults
Military personnel

The Armed Forces Radiobiology Research Institute, part of the Uniformed Services University, aims to preserve the health and performance of service members and humankind through medical and emergency response training to manage incidents related to radiation exposure.

HJF assists the institute’s research and development mission by helping develop methods of rapidly assessing radiation exposure to assure appropriate medical treatment and by pursuing new drugs that will prevent the life-threatening effects of ionizing radiation. The work includes moving those drugs from discovery through the Food and Drug Administration approval process.

Population(s) Served
Military personnel
Adults

The Center for Rehabilitative Sciences Research was established in 2011 to advance rehabilitative care for service members with combat-related injuries, particularly those with orthopedic trauma, limb loss and neurological complications.

The center explores innovative treatment and technology in four areas:

barriers to successful reintegration
improvements to pain management strategies
applications of new technologies
transfer of those technologies.

To provide comprehensive treatment strategies for service members, the center engages in personal interactions through ethnographic interviewing and uses the latest advances in technology to further understand physiology, gait and kinematics.

Population(s) Served
Military personnel
Adults

HJF partners with the U.S. Military HIV Research Program (MHRP) to spearhead an international collaborative research effort focused on the prevention, care and treatment of HIV/AIDS.

Scientific, technical and administrative personnel from HJF work closely with the Walter Reed Army Institute of Research on HIV vaccine development. This partnership has enabled the program to develop a robust international HIV clinical trial capability in several African nations as well as Thailand while providing prevention, care and treatment services in these countries.

The program’s RV144 HIV vaccine trial in Thailand in 2009, showed a vaccine regimen was safe and modestly effective in preventing HIV infection, a result that and propelled MHRP to the forefront of HIV vaccine development. The program partners with private industry, the Bill & Melinda Gates Foundation, and the National Institute of Allergy and Infectious Diseases in follow-up studies.

Population(s) Served
Adults
Military personnel

To improve traumatic brain injury (TBI) treatment and transform brain injury research, the U.S. Congress established the Center for Neuroscience and Regenerative Medicine (CNRM) in 2008. The center’s collaborative research efforts emphasize aspects of TBI that have high relevance to military populations.

CNRM works with the Unformed Services University of the Health Sciences, National Institutes of Health and Walter Reed National Military Medical Center. Their mission: to build an interdisciplinary collaboration to catalyze TBI research.

The center focuses on directed studies to accomplish multiple goals. Six programs were created to synthesize progress:

neuroimaging
biomarkers
neuroprotection
neuroregeneration
neuroplasticity
rehabilitation

Population(s) Served
Military personnel
Adults

Where we work

Our results

SOURCE: Self-reported by organization

How does this organization measure their results? It's a hard question but an important one.

Number of grants and research funding awarded to the institution

This metric is no longer tracked.
Totals By Year
Type of Metric

Output - describing our activities and reach

Direction of Success

Increasing

Context Notes

Grants and research studies managed by HJF.

Number of grants received

This metric is no longer tracked.
Totals By Year
Type of Metric

Output - describing our activities and reach

Direction of Success

Increasing

Context Notes

These are yearly, the total is 475.

Number of active research protocols the organization is supporting

This metric is no longer tracked.
Totals By Year
Type of Metric

Output - describing our activities and reach

Direction of Success

Holding steady

Number of scientific patents issued to organization

This metric is no longer tracked.
Totals By Year
Type of Metric

Output - describing our activities and reach

Direction of Success

Increasing

Our Sustainable Development Goals

SOURCE: Self-reported by organization

Learn more about Sustainable Development Goals.

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

HJF was created by the U.S. Congress in 1983 for the mission of advancing military medicine. A global nonprofit 501(c)(3) organization with a presence in more than a dozen countries, HJF provides scientific, administrative, and program management support to researchers, investigators, and clinicians.

HJF serves as a vital link between the military medical community and federal and private partners. By providing research and administrative support and capabilities, HJF makes it possible for military medical researchers and clinicians to focus on research and accomplish their goals.

HJF is named after the late U.S. senator who sponsored the legislation leading to its authorization by Congress in 1983, Henry M. Jackson.

HJF fulfills its mission to advance military medicine by serving as a link between the military, government, academia, and industry. Our partners include the Department of Defense (Army, Navy, Air Force), federal research organizations (Centers for Disease Control and Prevention, National Institutes of Health, etc.), universities (Uniformed Services University of the Health Sciences Duke, Emory, Johns Hopkins, University of Pittsburgh, etc.), industry (Carl Zeiss Meditec, Celgene, GSK, Janssen, Novartis, etc.), and foundations (Bill & Melinda Gates Foundation, etc.).

HJF’s support of international clinical research sites and laboratories enables military and civilian scientists to identify, anticipate and counter emerging infectious disease threats. One critical outcome of this strategy is that—together with the Department of Defense and the National Institutes of Health—we help maintain a clinical research infrastructure for vaccine development and testing around the world.

HJF brings nearly four decades of experience to conducting and managing research at domestic and international sites. Our 2,800 employees located at more than 75 sites worldwide offer a wide range of capabilities dedicated to supporting medical research. In addition, our global presence extends to more than a dozen countries (Georgia, Germany, Ghana, Jordan, Kenya, Liberia, Mozambique, Nigeria, South Africa, Tanzania, Thailand, and Uganda).

HJF has extensive experience in partnering with other leading organizations on medical research that focuses on combat casualties and golden hour care. Other key supported research areas are clinical and rehabilitative interdisciplinary medical research, including PTSD, TBI, and mental health mitigation and coping support.

HJF’s support capabilities include extensive experience studying infectious diseases, including HIV, Ebola, anthrax, malaria, SARS-CoV, MERS, H1N1, and Zika.

HJF offers a wide range of expertise that includes global health program management, scientific and medical research and program management staffing, meetings and medical education support, and editing, statistical analysis, and clinical trial protocol development.

By administering, managing, and supporting preeminent scientific programs, HJF supports research that benefits members of the armed forces and civilians alike. One example includes a an expansion of collaborative research in Western Kenya to address impacts to antenatal and postnatal outcomes by SARS-CoV2. There is limited data currently available on COVID-19 during pregnancy and this study will look to understand adverse pregnancy outcomes such as miscarriage, fetal distress and preterm births have been associated with maternal COVID-19. This type of research is what HJF facilitates both in the United States and globally.

In addition to supporting medical research, HJF offers other capabilities that involve clinical trial management, proposal and award management for multi-site research projects, federal as well as industry technology transfer and commercialization, IT support in global research environments, and public-private partnerships.

Since it was authorized by Congress in 1983, HJF has made significant progress that is reflected by our many accomplishments. In 2019 we marked the 10-year anniversary of the announcement of the results from the Army-led RV144 “Thai Study,” which was the first clinical trial to show efficacy in preventing HIV infection. HJF provided critical support to the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research that led the study in Thailand.

During the Ebola outbreak in Liberia, HJF supported the creation of a test kit for screening, helped set up a mobile lab and performed on-site tests that allowed non-positive patients to leave the hot zone more quickly. HJF also have played a key role in the development of research infrastructure at more than a dozen sites in African countries, and also supports HIV prevention and treatment through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). Many of these HJF-supported research laboratories are being leveraged for COVID-19 testing, which has substantially expanded testing capabilities in these countries.

In 2018 we accelerated the development of a human vaccine to end a quarantine of 2,000+ people in India due to an outbreak of Nipah virus. After the Indian government requested an experimental antibody for the virus, the HJF technology transfer office assisted in quickly completing multi-organizational agreements authorizing the transfer for compassionate use. These results led to an investment of $25 million for an innovative approach to funding vaccine development so that vaccines can be readily available in the future.

Shortly after the COVID-19 threat was identified, HJF joined other medical researchers around the world in the race to find a vaccine and treatments. In collaboration with the Emerging Infectious Diseases Branch of the Walter Reed Army Institute of Research, HJF is currently assisting with the development of a COVID-19 vaccine.

HJF is also supporting research on a variety of treatments for COVID-19. Along with the Walter Reed Army Institute of Research, which has screened more than 40 million compounds, we are helping to analyze a variety of promising drugs, including identifying and characterizing monoclonal antibodies, a type of immunotherapy that may treat and help prevent infection. HJF is also supporting the Infectious Disease Clinical Research Program at the Uniformed Services University in an adaptive clinical treatment trial of Remdesivir, an antiviral medication currently being tested as a treatment for COVID-19.

In addition to infectious diseases HJF supports research on a wide array of medical maladies.

Financials

Henry M Jackson Foundation for the Advancement of Military Medicine
lock

Unlock financial insights by subscribing to our monthly plan.

Subscribe

Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more about GuideStar Pro.

Operations

The people, governance practices, and partners that make the organization tick.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

Henry M Jackson Foundation for the Advancement of Military Medicine

Board of directors
as of 10/27/2021
SOURCE: Self-reported by organization
Board chair

Mr. Philip Odeen

Organizational demographics

SOURCE: Self-reported; last updated 10/27/2021

Who works and leads organizations that serve our diverse communities? GuideStar partnered on this section with CHANGE Philanthropy and Equity in the Center.

Leadership

The organization's leader identifies as:

Race & ethnicity
Multi-Racial/Multi-Ethnic (2+ races/ethnicities)
Gender identity
Male

Race & ethnicity

No data

Gender identity

No data

 

No data

Sexual orientation

No data

Disability

No data